KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Q3 2025 value amounting to $93.5 million.

  • Aurinia Pharmaceuticals' Change in Acquisitions & Divestments fell 2947.18% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $472.8 million, marking a year-over-year decrease of 2114.67%. This contributed to the annual value of $585.4 million for FY2024, which is 1058.64% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments is $93.5 million, which was down 2947.18% from $132.2 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments peaked at $170.5 million during Q1 2024, and registered a low of $60.9 million during Q1 2021.
  • In the last 5 years, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $120.5 million in 2022 and averaged $121.0 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments soared by 8143.42% in 2022 and then plummeted by 2947.18% in 2025.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Change in Acquisitions & Divestments stood at $90.7 million in 2021, then skyrocketed by 30.36% to $118.2 million in 2022, then increased by 16.82% to $138.1 million in 2023, then dropped by 10.22% to $124.0 million in 2024, then dropped by 24.58% to $93.5 million in 2025.
  • Its last three reported values are $93.5 million in Q3 2025, $132.2 million for Q2 2025, and $123.0 million during Q1 2025.